| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/09/2003 | US20030005751 Method for determining oil viscosity |
| 01/09/2003 | US20030005747 Method for detecting and correcting sensor failure in oil and gas production system |
| 01/09/2003 | US20030005746 Abnormality diagnosis system and method for oxygen sensor |
| 01/09/2003 | DE20213551U1 New monoclonal antibody specific for procollagenase 3, useful for diagnosing breast cancer, rheumatoid arthritis and osteoarthritis |
| 01/09/2003 | DE10164179C1 Process for adjusting ozone sensors for the onboard diagnosis of a catalytic element in a vehicle for splitting ozone, involves extracting release conditions for carrying out sensor adjustment |
| 01/09/2003 | CA2779653A1 Diagnostic assays for parvovirus b19 |
| 01/09/2003 | CA2764307A1 Assay plates, reader systems and methods for luminescence test measurements |
| 01/09/2003 | CA2486789A1 Compositions and methods for inferring a response to a statin |
| 01/09/2003 | CA2452690A1 Methods and compositions for determining the purity of and purifying chemically synthesized nucleic acids |
| 01/09/2003 | CA2452390A1 Use of tyrosine kinase inhibitors for treating bone loss |
| 01/09/2003 | CA2452368A1 New potent, selective and non toxic c-kit inhibitors |
| 01/09/2003 | CA2452202A1 Diagnostic methods and agents |
| 01/09/2003 | CA2452200A1 Method for identifying compounds that specifically deplete mast cells |
| 01/09/2003 | CA2452196A1 T cell regulatory genes and methods of use thereof |
| 01/09/2003 | CA2452195A1 Identification and characterization of multiple splice variants of the mu opioid receptor gene |
| 01/09/2003 | CA2452169A1 Use of tyrosine kinase inhibitors for treating inflammatory diseases |
| 01/09/2003 | CA2452094A1 Screening method for identifying cancer therapy-relevant compounds |
| 01/09/2003 | CA2452082A1 Extracellular messengers |
| 01/09/2003 | CA2451959A1 Nucleic acid participating in the formation of presenilin-2-gene exon 5-defective splicing variant |
| 01/09/2003 | CA2451844A1 Method for generating, screening and dereplicating natural product libraries for the discovery of therapeutic agents |
| 01/09/2003 | CA2451795A1 Cell-based high-throughput screening methods |
| 01/09/2003 | CA2451770A1 Method and apparatus for computer modeling of an adaptive immune response |
| 01/09/2003 | CA2451756A1 Diagnostic assays for parvovirus b19 |
| 01/09/2003 | CA2451317A1 T1r hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds |
| 01/09/2003 | CA2451286A1 Method for kidney disease detection by protein profiling |
| 01/09/2003 | CA2451218A1 Diagnosis and treatment of cancer |
| 01/09/2003 | CA2451129A1 Glaucoma treatments with reduced hyperpigmentation |
| 01/09/2003 | CA2450985A1 Polymer stabilized proteinases |
| 01/09/2003 | CA2450725A1 Methods of preparing multicolor quantum dot tagged beads and conjugates thereof |
| 01/09/2003 | CA2450710A1 Methods for the simultaneous detection of hcv antigens and hcv antibodies |
| 01/09/2003 | CA2450693A1 Measurement testing of blood specimens |
| 01/09/2003 | CA2450353A1 Use of a biochip for the diagnosis of sepsis or sepsis related syndrome |
| 01/09/2003 | CA2449105A1 Novel technology for genetic mapping |
| 01/09/2003 | CA2448746A1 Methods and compositions useful for the prediction of blood-brain barrier permeation |
| 01/09/2003 | CA2441208A1 Proteins, druggable regions of proteins and target analysis for chemistry of therapeutics |
| 01/09/2003 | CA2429429A1 Method for detecting calpain 3 activity in a biological sample and peptides for implementing said method |
| 01/09/2003 | CA2392154A1 Volume meter testing device |
| 01/08/2003 | WO2002012543A2 Two coloured fluorimetric protease assay |
| 01/08/2003 | EP1273920A2 Apparatus for analysis with means for automatic introduction of reference fluid for the apparatus |
| 01/08/2003 | EP1273919A1 Catalytic test device and method for the use thereof in material tests |
| 01/08/2003 | EP1273918A2 Method of selecting evolved binding members using a native epitope |
| 01/08/2003 | EP1273917A2 Acridinium ester labels having hydrophilic modifiers |
| 01/08/2003 | EP1273916A1 Measuring method for immunochromatographic test strip |
| 01/08/2003 | EP1273915A2 Biochemical analysis kit and method for exposing a stimulable phosphor sheet |
| 01/08/2003 | EP1273913A1 Method for the determination of the interaction of keratinocytes and neurons |
| 01/08/2003 | EP1273912A1 Method for determining alloy phase in plating layer and method for evaluating sliding property of alloy galvanized steel plate |
| 01/08/2003 | EP1273905A1 Method for determination of quality of paper for printing process |
| 01/08/2003 | EP1273888A2 Fluid sensing device and a process for determining changes in the type of fluid |
| 01/08/2003 | EP1272855A2 Multi-analyte diagnostic test for thyroid disorders |
| 01/08/2003 | EP1272854A1 Method for detecting a hormone disrupting activity of environmental pollutants |
| 01/08/2003 | EP1272853A2 Methods for identifying and using amyloid-inhibitory compounds |
| 01/08/2003 | EP1272852A1 Tpst-assay for diagnosis of autism and related disorders |
| 01/08/2003 | EP1272851A1 Method and device for detecting molecules by means of impedance spectroscopy |
| 01/08/2003 | EP1272850A2 Biosensor chip |
| 01/08/2003 | EP1272849A2 Biosensor, biosensor array and method for detecting macromolecular biopolymers with a biosensor |
| 01/08/2003 | EP1272848A1 Device and method for cytology slide preparation |
| 01/08/2003 | EP1272847A2 An immunoassay diagnostic probe and its use |
| 01/08/2003 | EP1272846A1 Compositions and methods for induction of proteins involved in xenobiotic metabolism |
| 01/08/2003 | EP1272843A2 Method for identifying regulators of protein-age formation |
| 01/08/2003 | EP1272841A1 Methods and computer software products for transcriptional annotation |
| 01/08/2003 | EP1272840A1 A method for protein structure alignment |
| 01/08/2003 | EP1272839A1 Method and apparatus for predicting ligand binding interactions |
| 01/08/2003 | EP1272833A1 Electrochemical biosensor readout meter |
| 01/08/2003 | EP1272832A1 Device and method for determining characteristics of a biomass |
| 01/08/2003 | EP1272829A1 Grid-waveguide structure for reinforcing an excitation field and use thereof |
| 01/08/2003 | EP1272827A1 Analyte detection & apparatus therefor |
| 01/08/2003 | EP1272768A2 Microfluidic devices and methods |
| 01/08/2003 | EP1272675A2 Detection of human papilloma viruses |
| 01/08/2003 | EP1272672A2 Method for detecting macromolecular biopolymers by means of an electrode arrangement |
| 01/08/2003 | EP1272671A2 Biosensor, biosensor array, method for producing an electrode of a biosensor, method for producing a biosensor |
| 01/08/2003 | EP1272670A2 Diagnosis of diseases associated with dna adducts |
| 01/08/2003 | EP1272668A2 Methods, compositions and kits for the detection and monitoring of breast cancer |
| 01/08/2003 | EP1272667A2 Method for immobilizing an analyte on a solid surface |
| 01/08/2003 | EP1272666A1 A functional assay of high-density lipoprotein |
| 01/08/2003 | EP1272665A1 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin |
| 01/08/2003 | EP1272664A2 A method of cell detection |
| 01/08/2003 | EP1272663A2 Polymorphisms in the human cyp2b6 gene and their use in diagnostic and therapeutic applications |
| 01/08/2003 | EP1272662A2 Detection of single nucleotide polymorphisms |
| 01/08/2003 | EP1272661A2 Homocysteine assay |
| 01/08/2003 | EP1272659A1 Early diagnosis of miscarriage in human beings |
| 01/08/2003 | EP1272657A2 Method and system for microorganism identification by mass spectrometry-based proteome database searching |
| 01/08/2003 | EP1272655A1 Stabilization of highly sensitive nucleic acid stains in aqueous solutions |
| 01/08/2003 | EP1272641A2 Serine-threonine kinase |
| 01/08/2003 | EP1272638A2 Drug metabolizing enzymes |
| 01/08/2003 | EP1272635A1 Cryptic-like secreted protein |
| 01/08/2003 | EP1272630A2 Methods and compositions for rna interference |
| 01/08/2003 | EP1272619A2 Human ovarian mesothelial cells and methods of isolation and uses thereof |
| 01/08/2003 | EP1272525A1 Novel antibodies specifically identifying inactive psa, and uses thereof |
| 01/08/2003 | EP1272522A1 Selectable marker genes |
| 01/08/2003 | EP1272518A2 Cd20/ige-receptor like molecules and uses thereof |
| 01/08/2003 | EP1272517A2 Multiprotein-complexes comprising a nmda receptor and uses thereof |
| 01/08/2003 | EP1272515A2 Immunoregulator |
| 01/08/2003 | EP1272514A1 Dna encoding human vanilloid receptor vr3 |
| 01/08/2003 | EP1272511A2 Molecules associated with human reproduction |
| 01/08/2003 | EP1272509A2 Prion-binding peptidic ligands and methods of using same |
| 01/08/2003 | EP1272503A1 DNA MOLECULES ENCODING L-GLUTAMATE-GATED CHLORIDE CHANNELS FROM i RHIPICEPHALUS SANGUINEUS /i |
| 01/08/2003 | EP1272465A2 Compounds and methods to increase plasma hdl cholesterol levels and improve hdl functionality |
| 01/08/2003 | EP1272440A2 High density porous materials |
| 01/08/2003 | EP1272439A2 Diagnostic devices containing porous material |
| 01/08/2003 | EP1272274A1 Method for producing biopolymer fields by means of real-time control |